Atlas Trials

Genetic Subtype-matched Targeted Therapy for the Treatment of Newly Diagnosed DLBCL With TP53 Mutation

Clinical trial NCT07499271 · RECRUITING

Trial details

NCT number
NCT07499271
Sponsor
The First Affiliated Hospital of Soochow University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Diffuse Large B-Cell Lymphoma (DLBCL)
Start date
2026-01-01
Primary completion
2027-12-31
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.